Andrew (Andy) Dorfmann, MS (ELD), is currently the Scientific Director of the Fairfax EggBank, Director of the Embryology Laboratory and was formerly the Director of the Prenatal Cytogenetics Laboratory at the Genetics & IVF Institute (GIVF) in Fairfax, VA. He received his B.S. in Biology from Syracuse University and his M.S. from George Washington University in Reproductive Genetics in 1985. He has over 30 years of experience in Assisted Reproductive Technologies and Prenatal Cytogenetics. In 1984 he co-founded GIVF and is currently a member of the Board of Directors of both GIVF and its main affiliate center in China, Shanghai Ji Ai. Mr. Dorfmann has been on the Executive Board of the Society of Biologists and Technologists since 2014 as Vice President and now President of this affiliated society of the ASRM.
Mr. Dorfmann was responsible for the initiation of several of the core laboratories and technologies at GIVF, including the Embryology lab, the Andrology lab, the Cytogenetics labs, and the Immunoassay lab. Early in the history of GIVF, he developed rapid turn-around procedures for both in situ Amniotic Fluid cell karyotyping and direct Chorionic Villus Cell karyotyping. Later, he introduced several embryologic methods to the GIVF ART clinic, such as ICSI, embryo biopsy and blastocyst culture. Mr. Dorfmann played an instrumental role in developing, designing, opening, and managing several GIVF affiliate centers in China. GIVF has had at various times, centers in Shanghai, Guangzhou and Harbin inside the People’s Republic of China. At present, Shanghai Ji Ai is one of the largest IVF centers in China performing over 6,000 IVF cycles each year.
In addition to his role as a clinical scientist, Mr. Dorfmann has developed, written and implemented several large database systems now in use at the GIVF Fairfax facility. He was a key member of the team working on the implementation of an electronic medical record and received a second Master’s Degree in Information Systems in 2005. He has participated in the development of several Use Cases at the Office of the National Coordinator for Healthcare Information Technology, encompassing subjects such as Personalized Healthcare, Clinical research, and others.